Skip to main content

Headlines

Ascletis' ASC50 Shows 48.9% PASI Reduction In Phase 1 Psoriasis Trial
posted:
by: Nasdaq News
#channels:: #All, #Business, #News, #Nasdaq, #NasdaqNews, #Stocks
Axed Sydney Data Center Shows Backlash to Australia’s AI Boom
posted:
by: Bloomberg BusinessWeek
#channels:: #All, #Business, #Technology, #Bloomberg, #BloombergBusinessWeek, #Stocks
NZ Election on Knife Edge as Greens Surge to 16%, Poll Shows
posted:
by: Bloomberg Politics
#channels:: #All, #Business, #Bloomberg, #BloombergPolitics, #Politics
The 1-Hour Test That Shows Where AI Will Actually Pay Off
posted:
by: Entrepreneur
#channels:: #All, #Business, #SmallBusiness, #Entrepreneur
Meta’s Muse Shows How AI Is Taking Over as the New Travel Agent
posted:
by: Bloomberg BusinessWeek
#channels:: #All, #Business, #Technology, #Bloomberg, #BloombergBusinessWeek, #Stocks
China saw 'surprise' jump in U.S. orders ahead of Trump-Xi summit, private survey shows
posted:
by: CNBC Economy
#channels:: #All, #Business, #Economy, #CNBCEconomy, #CNBC, #Stocks
CrowdStrike's quarter shows AI is a cybersecurity tailwind, not a threat
posted:
by: CNBC Earnings
#channels:: #All, #Business, #CNBCEarnings, #CNBC, #Earnings, #Stocks
Corn Closes Weaker, USDA shows Above Normal Planting Pace
posted:
by: Nasdaq Stocks
#channels:: #All, #Business, #Stocks, #Nasdaq, #NasdaqStocks
The Math Shows VAW Can Go To $221
posted:
by: Nasdaq ETFs
#channels:: #All, #Business, #Nasdaq, #NasdaqETFs, #ETFs, #Stocks
AZN:Datopotamab Deruxtecan Shows Favorable Survival Results, Falls Short Of Statistical Significance
posted:
by: Nasdaq FB FaceBook
#channels:: #All, #Business, #Technology, #Nasdaq, #Stocks, #FB, #FaceBook, #MetaPlatforms, #META
Macy’s beats earnings estimates, as turnaround plan shows early progress
posted:
by: CNBC Business
#channels:: #All, #News, #Business, #CNBCBusiness, #CNBC, #Stocks, #Markets
The Math Shows FXD Can Go To $68
posted:
by: Nasdaq FB FaceBook
#channels:: #All, #Business, #Technology, #Nasdaq, #Stocks, #FB, #FaceBook, #MetaPlatforms, #META
AstraZeneca: New Data Shows Tezspire's Role In Future COPD Treatment
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Gilead's Seladelpar Shows Major Liver Disease Progression Improvement, Itch Reduction In PBC Study
posted:
by: Nasdaq Markets
#channels:: #All, #Business, #Nasdaq, #NasdaqMarkets, #Stocks, #Markets
Positive Signal: Brian Healy Shows Faith, Buying $50K In Mueller Water Products Stock
posted:
by: CoinDesk Crypto
#channels:: #All, #Business, #Nasdaq, #NasdaqCryptocurrencies, #Cryptocurrencies, #Crypto, #CoinDesk